WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Boston Scientific says plants and shipping are fully back 17 days after the cyberattack ARPA-H commits $62.7M to autonomous heart failure AI and wants FDA packages in two years Glucotrack raises $11.5M in convertible notes at a 22 percent original issue discount Cardiovascular AI notification software gets its own Class II regulation and a 510(k) path CMS covers TAVR for asymptomatic patients and drops the evidence requirement for symptomatic ones FDA codifies eight De Novo device types as Class II, three years after granting them Axogen to pay $200M cash for BioCircuit and its sutureless NerveTape Nutromics wins Breakthrough designation for a microneedle patch that reads vancomycin levels Precera Medical buys Additive Metal Services to bring metal injection molding in house Boston Scientific says plants and shipping are fully back 17 days after the cyberattack ARPA-H commits $62.7M to autonomous heart failure AI and wants FDA packages in two years Glucotrack raises $11.5M in convertible notes at a 22 percent original issue discount Cardiovascular AI notification software gets its own Class II regulation and a 510(k) path CMS covers TAVR for asymptomatic patients and drops the evidence requirement for symptomatic ones FDA codifies eight De Novo device types as Class II, three years after granting them Axogen to pay $200M cash for BioCircuit and its sutureless NerveTape Nutromics wins Breakthrough designation for a microneedle patch that reads vancomycin levels Precera Medical buys Additive Metal Services to bring metal injection molding in house

Strategic investment

Nvidia takes its first equity stake in Verily

MedDevice Startups Staff · 3 days ago · 2 min read · Via MassDevice

Nvidia put equity into Verily for the first time on September 10. Neither company disclosed the amount. The CU Healthcare Innovation Fund, already an investor, added capital at the same time. The two companies have worked together since October 2025, so the check formalizes an arrangement that already existed.

Verily will spend it on the Pre platform, where researchers exchange biomedical data and run models, and on Verily Me, a patient app that reads symptoms and medical records. A third program, Forecast 1.0, is a multimodal model built on genomics and EHR data that predicts long term health risk. Alphabet has been a minority holder since it cut its controlling stake in March 2026.

None of the three carries an FDA authorization today. Forecast 1.0 is the one to watch, because a model that predicts risk for an individual drifts toward device territory the moment its output guides a clinical decision.

Questions & Answers

How much did Nvidia invest in Verily?

Neither company disclosed the amount of Nvidia's September 10, 2026 equity investment in Verily, which is Nvidia's first equity stake in the company.

What will Verily do with the Nvidia investment?

Verily said it will scale its Pre data and AI platform, the Verily Me patient app, and Forecast 1.0, a multimodal model built on genomics and electronic health record data that predicts long term health risk.

Does Alphabet still own Verily?

Alphabet has been a minority investor in Verily since it reduced its controlling stake in March 2026. The CU Healthcare Innovation Fund added capital alongside Nvidia in September 2026.

← Back to Fundraising